ARCHIVES

NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA

This article is from The Cancer Letter archive.

Vol. 09 No. 36 | September 23, 1983

Download PDF Visit The Full Archive

Related Articles

Vasopermeation Technology Awarded Patent For CA Firm.

September 28, 2001

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

NCI Publishes FOA For Trials Network Program

July 27, 2012

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

Reviews of the Faculty Report by Irwin Krakoff, Robert Cook-Deegan, and Michael Katz

March 29, 2013